IRONWOOD PHARMACEUTICALS, INC. (IRWD) Operating income 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) annual operating income history from SEC filings — each fiscal year as reported.
$98.5MFY2025 · since FY2016: -$51.9M → $98.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98.5M | +5.8% |
| FY2024 | $93.1M | +109.8% |
| FY2023 | -$945.4M | -477.7% |
| FY2022 | $250.3M | +7.8% |
| FY2021 | $232.3M | +62.5% |
| FY2020 | $142.9M | +19.0% |
| FY2019 | $120.1M | +179.7% |
| FY2018 | -$150.7M | -880.7% |
| FY2017 | -$15.4M | +70.4% |
| FY2016 | -$51.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating marginIRWD Operating cash flowIRWD Free cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Total liabilitiesIRWD Shareholders’ equityIRWD overview →